Brain-Boosting Hormone FGF19 Shows Promise in Combating Obesity & Metabolic Dysfunction
The escalating global obesity crisis demands innovative solutions,and a recent breakthrough from researchers at the State University of Campinas (UNICAMP) in Brazil offers a compelling new avenue for exploration. A study, published in the prestigious American Journal of Physiology – Endocrinology and Metabolism and highlighted as a “Top Article” in May, reveals that directly administering FGF19 – a hormone primarily known for its role in liver function – to the brains of obese mice substantially improved energy balance and boosted metabolism. This research, funded by the São Paulo Research Foundation (FAPESP), suggests a previously underappreciated link between brain-based FGF19 signaling and the fight against obesity.
The Looming Global Health Threat: Obesity & Its Consequences
The urgency of addressing obesity cannot be overstated. The World Atlas of Obesity 2025 paints a stark picture: current trends indicate global health targets for 2025 – including halting the rise in diabetes and obesity, and reducing premature deaths from related diseases by 25% – will likely be missed. Currently,over 1 billion people worldwide live with obesity,a number projected to exceed 1.5 billion by 2030. This epidemic is already responsible for an estimated 1.6 million premature deaths annually due to non-communicable diseases like cardiovascular disease, cancer, and chronic respiratory illnesses.
In Brazil, approximately 31% of the population is classified as obese, compounded by the fact that 40-50% of adults fail to meet recommended physical activity guidelines. These statistics underscore the critical need for effective interventions.
FGF19: Beyond the Liver – A Novel Target in the Brain
Fibroblast growth factor 19 (FGF19) has long been recognized for its crucial role in regulating energy metabolism,primarily through its actions in the liver. It controls bile acid production and influences glucose and fat synthesis. However,the impact of FGF19 within the brain has remained largely unexplored – until now.
“Given its association with metabolic regulation and obesity,it’d make a lot of sense,” explains Professor Helena Cristina de lima Barbosa,leading researcher at UNICAMP’s Obesity and Comorbidities Research Center (OCRC). This intuition drove the research team,led by doctoral student Lucas Zangerolamo,to investigate the potential of central FGF19 signaling.
Study Findings: Reversing Metabolic Dysfunction with Targeted FGF19 Delivery
The research team induced obesity in mice by feeding them a high-fat diet.They then directly administered FGF19 into the brains of the obese animals,while a control group received a standard diet.The results were striking.
The study demonstrated that central FGF19 signaling improved energy homeostasis by:
* Activating the sympathetic Nervous System: This “fight or flight” system was boosted, leading to increased energy expenditure.
* Stimulating Thermogenesis: Adipose (fat) tissue was prompted to burn more energy as heat, effectively increasing calorie expenditure.
These findings highlight the brain’s pivotal role in controlling body weight and suggest that manipulating FGF19 signaling could be a viable therapeutic strategy. ”The brain plays an extremely critically important role in controlling the body’s adiposity. Simultaneously occurring as it receives information from peripheral tissues, it triggers commands. These commands, apparently using the sympathetic nervous system, seem to be an engaging way of thinking about energy expenditure,” adds Professor Barbosa.
Unlocking the Cellular Mechanisms: Identifying FGF19 Receptors in the Hypothalamus
To pinpoint which brain cells respond to FGF19, the researchers leveraged cutting-edge single-cell RNA sequencing (scRNA-seq) technology.By analyzing publicly available data from multiple studies of the hypothalamus – a brain region critical for regulating appetite and metabolism – they identified specific hypothalamic cell populations that express FGF19 receptors. This analysis, encompassing data from over 50,000 individual cells, provides a crucial roadmap for future research.
Future Directions: Harnessing the Body’s Own FGF19 Production
While direct FGF19 governance showed promising results, the next critical step is to determine how to stimulate the body to produce more FGF19 naturally. The research team is also investigating the interplay between FGF19 signaling and neural circuits that govern eating behavior.
“We want to broaden this understanding. We’re studying the hypothalamus to evaluate the inflammation commonly observed when a high-fat diet is administered and whether FGF19 plays a role in this area,” explains zangerolamo, who conducted part of his research at the Joslin Diabetes Center at Harvard Medical School, collaborating with Professor Yu-Hua Tseng.